Furthermore, high NR2F1-AS1 expression has been reported in esophageal squamous cell carcinoma [25], hepatocellular carcinoma [26], endometrial cancer [27], and papillary thyroid carcinoma [28, 29]. This evidence concerns the gene NR2F1 and esophageal squamous cell carcinoma.